Navigation Links
Mylan Inc. Subsidiary, Dey, L.P., Announces that Perforomist(TM) (Formoterol Fumarate) Inhalation Solution is Now Available for Maintenance Treatment of COPD
Date:10/8/2007

- Emphysema and chronic bronchitis patients to benefit from rapid, long-lasting symptom control with twice-daily dosing of first nebulized

formoterol fumarate -

NAPA, Calif., Oct. 8 /PRNewswire-FirstCall/ -- Dey, L.P., a subsidiary of Mylan Inc. (NYSE: MYL), today announced the launch of Perforomist(TM) (formoterol fumarate) Inhalation Solution, which will be available nationwide through retail pharmacies, hospitals, long-term care facilities, and home healthcare companies. Perforomist(TM) Inhalation Solution is indicated for long-term, twice-daily maintenance treatment of bronchoconstriction for emphysema and chronic bronchitis, also known as Chronic Obstructive Pulmonary Disease (COPD).

The formoterol molecule is a rapid and long-acting beta2-agonist (LABA) that has been previously available in the U.S. in a dry powder formulation and has twenty years of worldwide experience. Perforomist(TM) Inhalation Solution is the first and only FDA-approved nebulized form of this molecule. Nebulizers convert liquid medication into a mist that patients inhale through a mouthpiece or face mask.

"In treating patients with moderate to advanced COPD, I have found LABAs to be very effective, and in particular I think formoterol provides excellent long-term symptom control," said Donald P. Tashkin, MD, FACP, FCCP, Professor of Medicine, David Geffen School of Medicine at the University of California at Los Angeles. "Since patients have difficulty adhering to complicated medication regimens, it's very helpful that Perforomist(TM) Inhalation Solution offers a twice-daily nebulized version of formoterol. I consider nebulization to be an especially effective way to deliver medication into
'/>"/>

SOURCE Dey, L.P.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 2014 /PRNewswire/ -   JOLT , a leading technology ... join its growing portfolio of startups. Next-level tech and ... JOLT accelerator, and Cohort four is no ... Since its launch in July 2012, JOLT ... of financing. Now at 23 investments, JOLT,s portfolio has ...
(Date:7/28/2014)... Wis. , July 28, 2014   Propeller ... respiratory disease, announced the hire of Brad Towle ... Towle will be responsible for driving the company,s sales ... broad experience in healthcare, and specifically his past role ... insight to the company at this pivotal time in ...
(Date:7/28/2014)... , July 28, 2014  InterMune, Inc. (NASDAQ: ... release its second quarter 2014 financial results at the ... 2014. A live conference call and webcast will be hosted ... day. Interested investors and others may participate ... +1 212-231-2900 (international), conference ID#21728775. A replay of the webcast ...
(Date:7/26/2014)... (PRWEB) July 26, 2014 Canada ... key market data on the Canada Endoscopy Visualization ... of US dollars, volume (in units) and average ... High-End Endoscopy Visualization Systems, Mid-Range Endoscopy Visualization Systems ... Report at http://www.marketresearchreports.biz/analysis/213254 . , The report ...
Breaking Biology Technology:JOLT Announces the Next 6 Startups to Join its Summer 2014 Cohort 2JOLT Announces the Next 6 Startups to Join its Summer 2014 Cohort 3Propeller Health Hires Brad Towle as Senior Vice President of Business and Client Development 2InterMune to Release Second Quarter Financial Results on August 6 2Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 2Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 3Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 4Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 5
... and for opening new food and beverage product categories ... 16 Frost & Sullivan, the international growth consulting ... 2008 North American Food and Beverage Probiotics Product Innovation ... strain, Ganeden BC30 (TM), for opening new development ...
... - The American Journal of Medicine , ... Medicine (AJM), one of Elsevier,s flagship health,sciences journals, has introduced ... forum where physicians and other,healthcare professionals can discuss the research ... Journal. , "The American ...
... Reduced Use of Chemicals Among Greatest Benefits , ... ... a few developing countries that have made significant progress in plant ... released, Dr. Elíbio Rech, a biotechnology researcher at Embrapa in Brazil, ...
Cached Biology Technology:Ganeden Biotech Receives Frost & Sullivan 'Probiotics Product Innovation' Award 2Ganeden Biotech Receives Frost & Sullivan 'Probiotics Product Innovation' Award 3Elsevier Introduces The American Journal of Medicine Blog 2Elsevier Introduces The American Journal of Medicine Blog 3New Online Video Features Brazilian Researcher Elbio Rech 2New Online Video Features Brazilian Researcher Elbio Rech 3
(Date:7/27/2014)... Microorganisms like bacteria and fungi can evade treatment by ... antifungal drugs. These permanent mutations were once thought to ... Now a new study has shown that microorganisms can ... as epimutations -- to gain the benefits of drug ... was discovered in a fungus called Mucor circinelloides, it ...
(Date:7/25/2014)... 25, 2014 In the first broad-scale estimate of air ... and collaborators calculated that trees are saving more than ... of acute respiratory symptoms. , While trees, pollution removal ... than 1 percent, the impacts of that improvement are ... reduced air pollution at nearly $7 billion every year ...
(Date:7/25/2014)... Boston, MA A study published online in the ... describes a novel approach to preventing cervical cancer based ... cervical cancer after removal of a discrete population of ... from a study that looked at squamocolumnar junction cells, ... canal and have been implicated as the origins of ...
Breaking Biology News(10 mins):Scientists discover new, noncommittal mechanism of drug resistance 2Scientists discover new, noncommittal mechanism of drug resistance 3First national study finds trees saving lives, reducing respiratory problems 2Clearing cells to prevent cervical cancer 2
... at the UAB,s Institute of Environmental Science and Technology ... analysed the potential of different species of microalgae for ... the quantity of lipids per cell (essential for obtaining ... of marine algae that has received little attention till ...
... Human Frontier Science Program Organization (HFSPO) is awarding $34 ... competition for the HFSP Research Grants. Applicants went through ... that started with 715 submitted letters of intent. This ... scientists) together with 23 Program Grants (involving 81 scientists). ...
... associate a picture with a reward, the reward by ... monkeys, visual cortex. This finding was made by neurophysiologists ... Medical School) and American colleagues using functional brain scans ... Neuron . Our visual perception is not determined ...
Cached Biology News:Microalgae could be a profitable source of biodiesel 2Impressive list of research teams for the 2013 HFSP Research Grants 2Reward linked to image is enough to activate brain's visual cortex 2
100 g monoclonal antibody which can immunocapture ~10 g of Complex IV from heart mitochondria. Also included are 2 mg of bovine heart mitochondria for control immunocapture....
Tropomyosin 4 [Tm4]...
IHC Select Anti-p53, prediluted,wild & mutant, a.a. 19-26, clone DO-7 Immunogen: Human p53 Available Date: 37775...
Nestin, Human...
Biology Products: